Evidence map›Paper›PMID 36522776›Full record

ArticleThrombosis journal2022

Serum interleukin 1β and sP-selectin as biomarkers of inflammation and thrombosis, could they be predictors of disease severity in COVID 19 Egyptian patients? (a cross-sectional study).

Sara El-Sayed Abd El-Ghani, Reham Mohammad Raafat Hamed, Ragaey Ahmad Eid, Ahmed Yassin Mohammed Ibrahim, Hoda M Abdel-Hamid, Walaa Abdelrahman, Raghda Ebaid Ibrahim, Manar Mahmoud Abdel-Aziz, Marwa Salah Mohamed

Open access · goldAbstract read
In one paragraph

Article in Thrombosis journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Endotheliopathy in Acute COVID-19 and Long COVID.International journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Article
  4. The Basic Principles of Pathophysiology of Venous Thrombosis.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sara El-Sayed Abd El-GhaniDepartment of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt. sara.elsayed@kasralainy.edu.eg.ORCID https://orcid.org/0000-0003-3619-3740
Reham Mohammad Raafat HamedDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID https://orcid.org/0000-0002-5526-2134
Ragaey Ahmad EidDepartment of Tropical Medicine, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.ORCID https://orcid.org/0000-0002-3077-8265
Ahmed Yassin Mohammed IbrahimDepartment of Critical Care Medicine, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Hoda M Abdel-HamidDepartment of Chest Diseases, Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID https://orcid.org/0000-0003-4536-7941
Walaa AbdelrahmanDepartment of Rheumatology, Faculty of Medicine, Cairo University, Cairo, Egypt.ORCID https://orcid.org/0000-0002-6531-2692
Raghda Ebaid IbrahimDepartment of Clinical & Chemical Pathology, Faculty of Medicine, Beni Suef University, Beni-Suef, Egypt.
Manar Mahmoud Abdel-AzizDepartment of Clinical & Chemical Pathology, Faculty of Medicine, Beni Suef University, Beni-Suef, Egypt.
Marwa Salah MohamedDepartment of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Cairo University · EGBeni-Suef University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThromboembolism was a chief cause of mortality in 70% of patients with COVID-19. Our objective was to see if serum interleukins 1 beta (IL-1β) and soluble platelets selectin (sP-selectin) could serve as novel markers of thromboembolism in COVID-19 patients.

methodsThis cross sectional study involved 89 COVID-19 patients who were recruited from 1st of February to 1st of May 2021. Clinical and laboratory data were collected, and chest imaging was performed. The levels of IL-1β and sP-selectin were assessed in all cases through ELISA kits. Comparisons between groups were done using an unpaired t-test in normally distributed quantitative variables. In contrast, a non-parametric Mann-Whitney test was used for non-normally distributed quantitative variables.

resultsSevere COVID-19 infection was associated with higher serum levels of CRP, Ferritin, LDH, D dimer, IL-1β and sP-selectin (P <  0.001) with significant correlation between levels of IL-1β and sP-selectin (r 0.37, P <  0.001), D-dimer (r 0.29, P 0.006) and Ferritin (r 0.5, p <  0.001). Likewise, a positive correlation was also found between levels of sP-selectin, D-dimer and Ferritin (r 0.52, P <  0.001) (r 0.59, P <  0.001). Imaging studies revealed that 9 (10.1%) patients developed venous and 14 (15.7%) developed arterial thrombosis despite receiving anticoagulant therapy. Patients with thrombotic events had significantly higher levels of IL-1β, sP-selectin and LDH serum levels. Meanwhile, there was no statistical significance between CRP, D-dimer or Ferritin levels and the development of thrombotic events.

conclusionIL-1β and sP-selectin levels can be promising predictors for severe COVID-19 infection and predictable thrombosis.

Indexed as

COVID-19 severityIL-1βsP-selectinThromboembolism

Identifiers

PMID36522776
PMCPMC9754776
OpenAlexW4311569798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.